Phase 2 Study of NBP For Patients With Acute Ischemic Stroke "SUNRISE"


Phase 2 Results N/A

Summary of Purpose

This is a Phase 2 multicenter, randomized, double-blind, placebo-controlled, add-on to standard of care study of NBP softgel capsules for the treatment of mild to moderate AIS in adults.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 April 2018.

26 Feb 2018 23 Aug 2016 1 Nov 2020 1 Nov 2020 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


See All